Works matching IS 11096535 AND DT 2025 AND VI 22 AND IP 1


Results: 13
    1
    2
    3
    4
    5
    6
    7

    Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma.

    Published in:
    Cancer Genomics & Proteomics (1109-6535), 2025, v. 22, n. 1, p. 81, doi. 10.21873/cgp.20489
    By:
    • AMONTAILAK, SUPAKAN;
    • TITAPUN, ATTAPOL;
    • JUSAKUL, APINYA;
    • THANAN, RAYNOO;
    • KIMAWAHA, PHONGSARAN;
    • JAMNONGKAN, WASSANA;
    • THANEE, MALINEE;
    • SIRITHAWAT, PAPITCHAYA;
    • HAOHAN, SONGPOL;
    • TECHASEN, ANCHALEE
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors.

    Published in:
    Cancer Genomics & Proteomics (1109-6535), 2025, v. 22, n. 1, p. 1, doi. 10.21873/cgp.20481
    By:
    • TOMOYUKI ISHIGURO;
    • KAZUYUKI TAKEDA;
    • DAISUKE TAKAYANAGI;
    • EMIKO MURA;
    • RISAKO SUZUKI;
    • TOSHIAKI TSURUI;
    • NANA IRIGUCHI;
    • YUYA HIRASAWA;
    • RYOTARO OHKUMA;
    • MASAHIRO SHIMOKAWA;
    • HIROTSUGU ARIIZUMI;
    • YUTARO KUBOTA;
    • ATSUSHI HORIIKE;
    • MASAHIKO IZUMIZAKI;
    • SATOSHI WADA;
    • KIYOSHI YOSHIMURA;
    • HOFFMAN, ROBERT M.;
    • TAKUYA TSUNODA
    Publication type:
    Article